Es-Reflujo: estudio epidemiológico nacional de acidez y reflujo en Farmacia Comunitaria. Resultados preliminares, caracterización de la población / Es-Reflujo: national epidemiological study of heartburn and reflux in Community Pharmacy. Preliminary results, characterisation of the population

JUSTIFICACIÓN: la farmacia comunitaria (FC) es el principal punto de consulta por síntomas de acidez y/o reflujo. El correcto manejo de estos pacientes requiere herramientas validadas que faciliten la actuación profesional y la coordinación asistencial.OBJETIVO: el proyecto Es-REFLUJO tiene como objetivo analizar las características clínicas y sociodemográficas de los pacientes que consultan por acidez y/o reflujo en FC y evaluar el impacto de un Servicio de Indicación Farmacéutica, protocolizado según algoritmo de toma de decisiones en acidez y reflujo en FC y Atención Primaria, avalado por SEMERGEN y SEFAC.MÉTODOS: estudio observacional descriptivo transversal donde se evaluaron las características de los pacientes que consultaron por síntomas compatibles con acidez y/o reflujo o demandaron algún medicamento sin receta para esta sintomatología, durante el período de estudio. Tras aplicar el algoritmo, pasados 14 días una monitora epidemiológica externa (MEE), contactaba con el paciente para evaluar resultados clínicos y humanísticos de la intervención. Esta MEE también mantenía contacto periódico con los farmacéuticos investigadores. Aspectos éticos: dictamen favorable CEIC, clasificación NO-EPA AEMPS, Registro ClinicalTrial: NCT05162079.Resultados: análisis descriptivo población ES-REFLUJO. Participaron 134 FC y 207 farmacéuticos de SEFAC y/ o colaboradores de investigación con Universidad Miguel Hernández. Se incluyeron 1360 pacientes (tamaño muestral requerido), en su mayoría mujeres (N= 807;59,3 %), media de edad de 49,64 años (D.E.:16,54), nivel de estudios secundarios (N=470;34,6 %) o universitarios (N=474;34,9 %), no fumadores (N=699;61,4 %) y la mayoría (N=796;58,5 %) realizaban ejercicio físico regularmente. 827 pacientes (60,8 %) demandaron directamente algún medicamento sin receta, principalmente antiácidos (573;42,1 %) o alginatos- antiácidos (108;7,9 %). (AU)

Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies.

BACKGROUND: Patient adherence to treatment in chronic obstructive pulmonary disease (COPD) is essential to optimize disease management. We aimed to assess the impact of patients' perception of their treatment and disease on adherence and Health-Related Quality of Life (HRQL) in patients attending a community pharmacy, where usually subjects have a better condition than those in clinical settings. METHODS: We performed a cross-sectional study of 318 patients with COPD in treatment with inhalers in the last 3 months from 53 community pharmacies. We assessed HRQL with St George's Respiratory Questionnaire (SGRQ). Persistence was assessed from the three previous refills and adherence through the Test of Adherence to Inhalers test. RESULTS: Persistence was achieved by 78.6% of the patients and 58.5% had good adherence. Patients having a multidose DPI and those with MDI showed a 2.8-fold and 4.1-fold increased association, respectively, with intermediate/poor adherence in comparison with those having a single dose DPI. Those patients who did not have knowledge about COPD (aOR 2.106, p = 0.006) and those who thought that the inhaler effectiveness was fair/poor (aOR 2.361, p = 0.006) were more likely to have intermediate/poor adherence. Overall SGRQ score was significantly worse in patients with intermediate/poor adherence (p = 0.036) and in those who thought the inhaler's effectiveness was fair/poor (p < 0.001). CONCLUSIONS: The type of inhaler and patients' knowledge and perceptions of their disease and treatment were associated with good adherence and higher HRQL. Clinicians should promote shared-decision making in the choice of inhaler depending on patients' individual abilities and beliefs.

Impact of changes in pill appearance in the adherence to angiotensin receptor blockers and in the blood pressure levels: a retrospective cohort study.

OBJECTIVE: To assess the level of adherence to angiotensin receptor blockers (ARBs) in patients regularly attending a community pharmacy and the influence of a change in patients' adherence to pharmacological treatment. DESIGN: Retrospective cohort study of a random sample of consecutive patients collecting their medication. SETTING: 40 community pharmacies in Alicante (Southeast Spain). PARTICIPANTS: 602 consecutive ≥18 years old patients following treatment with ARBs at least 3 previous refills were included. MAIN OUTCOME MEASURES: Prevalence of uncontrolled blood pressure (BP) and adherence to prescribed pharmacological treatment (measured through both the Batalla and the Morisky-Green tests). A multivariate Poisson regression model was used to estimate the adjusted risk ratio (RRa) for non-adherence to pharmacological treatment by the presence of a change in patient's adherence and other significant variables. RESULTS: 161/602 (13.7%) patients presented uncontrolled BP. According to the Morisky test, 410/602 (68.2%) patients were considered adherent to pharmacological treatment and 231/602 (38.4%) patients according to the Batalla test. According to the Morisky-Green test, in the multivariable analysis, patients with a previous change in pill appearance were less likely to be adherent than those patients with no change in their pharmacological treatment (RRa 0.45; CI 95% 0.22 to 0.90; p=0.024). Systolic BP was higher in patients with a change in pill appearance in the previous 3 refills (median BP 142 mm Hg; IQR 136-148) than in those who did not have a change (median BP 127 mm Hg; IQR 118-135; p<0.001). CONCLUSIONS: There was a low percentage of adherence and nearly 15% of uncontrolled BP in patients who regularly collected their medication. Switching between pills of different appearances was associated with lower patient adherence to pharmacological treatment and a higher uncontrolled BP than no change in pharmacological treatment or change only in package but not in pill appearance.

Evaluation of clinicians' knowledge and practices regarding medical radiological exposure: findings from a mixed-methods investigation (survey and qualitative study).

OBJECTIVES: To assess the impact of initiatives aiming to increase clinician awareness of radiation exposure; to explore the challenges they face when communicating with patients; to study what they think is the most appropriate way of communicating the long-term potential risks of medical radiological exposure to patients. DESIGN: A quantitative and qualitative evaluation through a survey and focal groups. SETTING: San Juan Hospital and Dr Peset Hospital (Southeast Spain) and clinicians from Spanish scientific societies. PARTICIPANTS: The surveys were answered (a) in person (216: all the radiologists (30), urologists (14) and surgeons (44) working at both participant hospitals; a sample of general practitioners from the catchment area of one hospital (45), and a consecutive sample of radiologists attending a scientific meeting (60)) or (b) electronically through Spanish scientific societies (299: radiologists (45), pneumologists (123), haematologists (75) and surgeons (40)). Clinicians were not randomly selected and thus the results are limited by the diligence of the individuals filling out the survey. PRIMARY AND SECONDARY OUTCOME MEASURES: Clinicians' knowledge and practices regarding medical radiological exposure, and what they considered most appropriate for communicating information to patients. RESULTS: Nearly 80% of the clinicians surveyed had never heard of the European recommendations. Fewer than 20% of the clinicians surveyed identified correctly the radiation equivalence dose of intravenous urography or barium enema. It was reported by 31.7% that they inform patients about the long-term potential risks of ionising radiation. All participants agreed that the most appropriate way to present information is a table with a list of imaging tests and their corresponding radiation equivalence dose in terms of chest X-rays and background radiation exposure. CONCLUSIONS: Medical radiological exposure is frequently underestimated and rarely explained to patients. With a clear understanding of medical radiological exposure and proper communication tools, clinicians will be able to accurately inform patients.

Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study.

OBJECTIVE: To determine the prevalence of solitary pulmonary nodules (SPNs) in chest radiology studies and patient's features associated with malignancy in a non-high-risk clinical population. METHODS: Patients ≥35 years were referred for thoracic imaging in two hospitals (2010-2011). Eight radiologists determined the presence and characteristics of SPN. Selected variables were collected from radiological register and medical records. Observer agreement in the diagnosis of SPN was assessed. RESULTS: 25,529 patients were included: 23,102 (90.5%) underwent chest radiograph and 2,497 (9.5%) a CT. The prevalence of SPN was 2.1% (95% CI 1.9 - 2.3) in radiographs and 17.0% (95% CI 15.5 - 18.5) in CT. In patients undergoing chest radiograph, detection of SPN with an irregular border was more frequent among smokers. In patients who had a CT, larger SPNs appeared to be associated with 60 years of age or over, diagnosis of a respiratory illness, or male gender. In addition, an irregular border was also more common among men. CONCLUSIONS: The prevalence of SPNs detected by both radiograph and CT was lower than that shown in screening studies. Patient characteristics such as age, sex, respiratory disease, or smoking habit were associated with nodule characteristics that are known to be related with malignancy. KEY POINTS: There is a lower SPN prevalence in the clinical population than in screening studies. SPN prevalence is associated with some patient characteristics: sex, age, imaging test. Nodule characteristics related to malignancy were associated with some patient characteristics.

La Epidemiología en la Salud Pública del futuro

El paso desde una investigación epidemiológica de factores de riesgo a una investigación de carácter poblacional, centrada en las teorías etiológicas y más ligada al contexto social y ambiental podría aportar conocimientos que favorezcan la implantación de políticas públicas dirigidas a mejorar la salud de la población, pero no lo garantizan.

Incidental findings in imaging diagnostic tests: a systematic review.

The objective of this review is to summarise the available evidence on the frequency and management of incidental findings in imaging diagnostic tests. Original articles were identified by a systematic search of the MEDLINE, EMBASE and Cochrane Library Plus databases using appropriate medical headings. Extracted variables were study design; sample size; type of imaging test; initial diagnosis; frequency and location of incidental findings; whether clinical follow-up was performed; and whether a definitive diagnosis was made. Study characteristics were assessed by one reviewer and checked by a second reviewer. Any disagreement was solved by consensus. The relationship between the frequency of incidental findings and the study characteristics was assessed using a one-way ANOVA test, as was the frequency of follow-up of incidental findings and the frequency of confirmation. 251 potentially relevant abstracts were identified and 44 articles were finally included in the review. Overall, the mean frequency of incidental findings was 23.6% (95% confidence interval (CI) 15.8-31.3%). The frequency of incidental findings was higher in studies involving CT technology (mean 31.1%, 95% CI 20.1-41.9%), in patients with an unspecific initial diagnosis (mean 30.5, 95% CI 0-81.6) and when the location of the incidental findings was unspecified (mean 33.9%, 95% CI 18.1-49.7). The mean frequency of clinical follow-up was 64.5% (95% CI 52.9-76.1%) and mean frequency of clinical confirmation was 45.6% (95% CI 32.1-59.2%). Although the optimal strategy for the management of these abnormalities is still unclear, it is essential to be aware of the low clinical confirmation in findings of moderate and major importance.

A simple G-computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease.

Progression of a chronic disease can lead to the development of secondary illnesses. An example is the development of active tuberculosis (TB) in HIV-infected individuals. HIV disease progression, as indicated by declining CD4 + T-cell count (CD4), increases both the risk of TB and the risk of AIDS-related mortality. This means that CD4 is a time-dependent confounder for the effect of TB on AIDS-related mortality. Part of the effect of TB on AIDS-related mortality may be indirect by causing a drop in CD4. Estimating the total causal effect of TB on AIDS-related mortality using standard statistical techniques, conditioning on CD4 to adjust for confounding, then gives an underestimate of the true effect. Marginal structural models (MSMs) can be used to obtain an unbiased estimate. We describe an easily implemented algorithm that uses G-computation to fit an MSM, as an alternative to inverse probability weighting (IPW). Our algorithm is simplified by utilizing individual baseline parameters that describe CD4 development. Simulation confirms that the algorithm can produce an unbiased estimate of the effect of a secondary illness, when a marker for primary disease progression is both a confounder and intermediary for the effect of the secondary illness. We used the algorithm to estimate the total causal effect of TB on AIDS-related mortality in HIV-infected individuals, and found a hazard ratio of 3.5 (95 per cent confidence interval 1.2-9.1).

Meat intake and bladder cancer in a prospective study: a role for heterocyclic aromatic amines?

BACKGROUND: The suspect carcinogens, heterocyclic amines (HAAs), found in well-done meat require host-mediated metabolic activation before inducing DNA mutations. The role of SULT1A1 and of NAT2 on the activation of HAAs suggests that NAT2 rapid acetylator genotype and SULT1A1 allele variants can have an effect on HAA carcinogenicity. METHODS: Data were collected as part of a case-control study nested within the EPIC cohort, the Gen Air investigation. EPIC is a prospective study designed to investigate the relationship between nutrition and cancer. Information was collected through a non-dietary questionnaire on lifestyle variables and through a dietary questionnaire. The subjects were restricted to non-smokers. We calculated the matched odds ratio for bladder cancer risk using logistic regression, controlling for potential confounders. RESULTS: There were 227 bladder cases and 612 controls matched 1:3. Meat intake and NAT2 genotype were not independently associated with bladder cancer risk. A significant relationship was observed between bladder cancer risk and consumption of meat only among subjects with the rapid NAT2 genotype (odds ratios [OR] 2.9, 95% CI 1.0-7.9 for the 2nd quartile of meat intake; 3.6, 95% CI 1.3-9.7 for the 3rd quartile; and 3.5, 95% CI 1.2-9.7 for the 4th quartile), and was not present among subjects with the slow genotype. An interaction between NAT2 and meat intake was found in logistic regression (P = 0.034). No association was observed for SULT1A *1/2 genotype (1.0; 95% CI 0.7-1.5) and for SULT1A1 *2/2 genotype (0.9; 95% CI 0.5-1.7). CONCLUSIONS: These results are suggestive of a role of meat intake and NAT2 on bladder cancer risk. They support the hypothesis that among subjects with the rapid NAT2 acetylation genotype higher levels of HAAs exposure are a bladder cancer risk factor. We did not observe an effect of SULT1A1 allele variants on this cancer. The present study adds new information on the possible long-term adverse effects of diets with high meat intake.

Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.

BACKGROUND: We assessed the impact of education on long-term overall and cause-specific mortality among 6575 injecting drug users (IDUs) according to HIV status and introduction of highly active antiretroviral therapy (HAART). METHODS: Community-based cohort study of IDUs recruited in three AIDS prevention centres (1987-1996). Causes of death were ascertained in clinical centres and Mortality Registry and classified as AIDS, drug use related, injuries, or liver diseases. Poisson regression models including education and calendar period interaction and adjusted by sex, age, and HIV were used. RESULTS: In 73 901 person-years of follow-up, there were 1493 deaths (20.2/1000 person-years): 761 related to AIDS, 234 to drug use, 179 to injuries, and 93 to liver diseases. IDUs with university studies had a lower risk of death (RR 0.52; 95% CI 0.36-0.77) than those without studies: this difference was higher after (RR 0.45; 95% CI 0.25-0.80) than before 1997 (RR 0.68; 95% CI 0.41-1.13). Compared to before 1997, while decreases in the risk of AIDS mortality were seen during 1997-2004 for both lower (RR 0.49; 95% CI 0.41-0.58) and higher (RR 0.33; 95% CI 0.23-0.48) educated, only those higher educated experienced a reduction in drug-use mortality (RR 0.54; 95% CI 0.28-1.05) and death from injuries (RR 0.52; 95% CI 0.23-1.21). CONCLUSIONS: Independently of HIV status, lower education predicts a higher risk of death in IDUs and its impact is stronger after 1997. Education has a protective effect on most causes of death and it cannot be entirely attributable to the access or use of HAART.

Aplicación de una técnica de lavado seminal en pacientes infectados por VHC y coinfectados con VIH / Application of a technique of seminal washing in patients infected by VHC and co-infected with HIV

Objetivo Estudiar el aclaramiento de la carga viral en muestras de semen en pacientes con VHC y coinfectados con VIH tras realizar dos lavados seguidos de swim-up. Diseño experimental Estudio longitudinal prospectivo Pacientes Once pacientes con serología VHC positiva, seis de ellos coinfectados por VIH. Métodos Las muestras de semen se recogieron por masturbación, extrayéndose el mismo día muestras sanguíneas a los pacientes para la determinación de carga viral plasmática (CVP), genotipaje VHC, poblaciones linfocitarias CD4/CD8, anticuerpos anti-VHC y serología VIH: En una alícuota inicial se hizo el seminograma y al resto del semen se le realizaron dos lavados con medio de cultivo, seguidos de un swim-up determinándose CV seminal en todas las fracciones plasmáticas y celulares en el Cobas Amplicor HIV monitor 1.5 y Cobas TaqMan HCV. Resultados Grupo VHC (edad 37,2 años; 60% genotipo 3; anticuerpos anti VHC: 35,3; CVP-VHC: 1xl06 copias ARN/ml. Grupo coinfección (edad 34,5 años; 80% genotipo 3; media anticuerpos anti-VHC: 34,8, CVP-VHC: 4xlOS copias ARN/ml. No se detectó CV seminal- VHC en ninguna de las muestras de semen detectándose CV seminal- VIH en el 85% de las muestras, siendo sus medias en las distintas fracciones seminales: Sedimento celular inicial: 1,8xl03 copias ARN+ADN/ml; Plasma seminal inicial: 8,9xl03 copias ARN/ml; Primer lavado: 4, 7xl 04 copias ARN/ml; Segundo lavado: 876 copias ARN/ml; Swim-up: Indetectable en todos los pacientes. Conclusiones El protocolo de dos lavados seguido de swim-up nos permite eliminar hasta límites indetectables la CV seminal en los pacientes a estudio. Los resultados del estudio deben ser completados con una casuística mayor

Objective To study the clearance of the viralload in samples of semen in patients with VHC and co-infected with HIV alter two washings followed by swim-up. Experimental design Prospective longitudinal study. Patients Eleven patients with positive serology VHC, six of them co-infected by HIV: Methods The samples of semen were laten by masturbation. The same day, blood samples were extracted from patients for the determination of plasmatic viral load (CVP), genotype VHC, linfocyte populations CD4/CD8, antibodies anti-VHC and HIV serology. In an initial sample a seminograme was carried out.To the rest of the semen samples the following was carried out: two washings to culture medium followed by a swim-up finding out the seminal CV in all the plasmatic and cellular fractions in the Cobas Amplicor HIV 1,5 monitor and Cobas TaqMan HCV: Results Group VHC (age 37,2 years; 60% genotype 3; antibodies anti VHC: 35.3,. CVP-VHC: lxl06 copiesRNA/mililiter: Group co-infection (age 34,5 years; 80% genotype 3; average antibodies anti VHC:34.8, CVP-VHC: 4xl05 copies RNA/mililiter: lt was not detected CV seminal- VHC in any of the samples of semen detecting itself CV seminal- VIH in 85% of the samples being its averages in the different seminal fractions: lnitial cellular sediment: 1.8xl03 copies RNA+DNAmililiter; lnitial seminal plasma: 8.9xl03 copies RNA/mililiter; First washing: 4.7xl04 copies RNA/mililiter; Second washing: 876 copies RNA/mililiter; Swim-up: Indetectable in all the patients. Conclusions The protocol of the two washings followed by a swim-up allows us to reduce below detectable levels the seminal CV in the population of the study. The result must be completed with a greater number of patients

Analysis for crystals in synovial fluid: training of the analysts results in high consistency.

BACKGROUND: Identification of monosodium urate (MSU) and calcium pyrophosphate dehydrate (CPPD) crystals in synovial fluid samples is diagnostic of gout and CPPD crystal related arthropathy. Various studies have shown poor consistency in results of crystal analysis. OBJECTIVE: To determine whether training of the analysts increases the consistency. METHODS: An expert rheumatologist gave a course on crystal detection and identification. The four trained observers then blindly and independently examined synovial fluid samples previously classified by the expert which had been obtained from patients with both crystal arthropathies and other non-crystal related inflammatory joint conditions. RESULTS: 194 observations were made on 64 synovial fluid samples: 96 without crystals (49.4%), 55 with CPPD crystal (28.4%), and 43 with MSU crystals (22.2%). For crystal detection (presence or absence of crystals), sensitivity was 95.9% and specificity 86.5%. For identification of MSU crystals, sensitivity was 95.3% and specificity 97.2%. For identification of CPPD crystals, sensitivity was 92.7% and specificity 92.1%. The kappa index of agreement with the reference standard between the observers was 0.84 for any crystal detection, 0.93 for MSU crystal sample identification, and 0.79 for CPPD crystal sample identification. CONCLUSIONS: For trained observers, the detection and identification of crystals in synovial fluid is a consistent procedure.